Immunity

Diseases, Conditions, Syndromes

Insights from patient who cleared hepatitis C could lead to vaccine

By studying individuals who spontaneously clear hepatitis C infections, a team of researchers has identified viable vaccine targets for a disease that infects 70 million worldwide with case numbers increasing every year.

Diseases, Conditions, Syndromes

Scientists find weak points on Epstein-Barr virus

Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this ...

page 2 from 40